K181537 is an FDA 510(k) clearance for the GLOW800. Classified as System, X-ray, Angiographic (product code IZI), Class II - Special Controls.
Submitted by Leica Microsystems (Schweiz) AG (Heerbrugg, CH). The FDA issued a Cleared decision on September 7, 2018 after a review of 88 days - a notably fast clearance cycle.
This device falls under the Neurology FDA review panel, regulated under 21 CFR 892.1600 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.